Array-CGH and breast cancer

Por van Beers, Erik H, Nederlof, Petra M
Publicado em 2006

Automated array-CGH optimized for archival formalin-fixed, paraffin-embedded tumor material

Por Joosse, Simon A, van Beers, Erik H, Nederlof, Petra M
Publicado em 2007

Multifocal Myxoid Liposarcoma—Metastasis or Second Primary Tumor?: A Molecular Biological Analysis

Por de Vreeze, Ronald, de Jong, Daphne, Nederlof, Petra, Ruijter, Henrique J., Boerrigter, Lucie, Haas, Rick, van Coevorden, Frits
Publicado em 2010

BRCA1 tumor suppression occurs via heterochromatin mediated silencing

Por Zhu, Quan, Pao, Gerald M., Huynh, Alexis M., Suh, Hoonkyo, Tonnu, Nina, Nederlof, Petra, Gage, Fred H., Verma, Inder M.
Publicado em 2011

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Por van Amerongen, Rosa A, Retèl, Valesca P, Coupé, Veerle MH, Nederlof, Petra M, Vogel, Maartje J, van Harten, Wim H
Publicado no Ecancermedicalscience (2016)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Por van de Vijver Marc J, Børresen-Dale Anne-Lise, Langerød Anita, Velds Arno, Horlings Hugo M, Holstege Henne, Nederlof Petra M, Jonkers Jos
Publicado em 2010-11-01

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets

Por Nederlof Petra M, van Beers Eric H, van de Vijver Marc J, Horlings Hugo M, Lai Carmen, Wessels Lodewyk FA, Reinders Marcel JT
Publicado em 2007-10-01

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets

Por Lai, Carmen, Horlings, Hugo M, van de Vijver, Marc J, van Beers, Eric H, Nederlof, Petra M, Wessels, Lodewyk FA, Reinders, Marcel JT
Publicado em 2007

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Por Holstege, Henne, Horlings, Hugo M, Velds, Arno, Langerød, Anita, Børresen-Dale, Anne-Lise, van de Vijver, Marc J, Nederlof, Petra M, Jonkers, Jos
Publicado em 2010

Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience

Por de Vreeze, Ronald S. A., de Jong, Daphne, Nederlof, Petra M., Ariaens, Aafke, Tielen, Ivon H. G., Frenken, Luc, Haas, Rick L., van Coevorden, Frits
Publicado em 2009

Delineation of Chondroid Lipoma: An Immunohistochemical and Molecular Biological Analysis

Por de Vreeze, Ronald S. A., van Coevorden, Frits, Boerrigter, Lucie, Nederlof, Petra M., Haas, Rick L., Bras, Johannes, Rosenwald, Andreas, Mentzel, Thomas, de Jong, Daphne
Publicado em 2011

BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer

Por Lips, Esther H., Benard-Slagter, Anne, Opdam, Mark, Scheerman, Caroline E., Wesseling, Jelle, Hogervorst, Frans B. L., Linn, Sabine C., Savola, Suvi, Nederlof, Petra M.
Publicado no Breast Cancer Res (2020)

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Por Puppe, Julian, Drost, Rinske, Liu, Xiaoling, Joosse, Simon A, Evers, Bastiaan, Cornelissen-Steijger, Paulien, Nederlof, Petra, Yu, Qiang, Jonkers, Jos, van Lohuizen, Maarten, Pietersen, Alexandra M
Publicado em 2009

Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness

Por Lips, Esther H, Laddach, Nadja, Savola, Suvi P, Vollebergh, Marieke A, Oonk, Anne MM, Imholz, Alex LT, Wessels, Lodewyk FA, Wesseling, Jelle, Nederlof, Petra M, Rodenhuis, Sjoerd
Publicado em 2011

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer

Por Hilbers, Florentine S., van ‘t Hof, Peter J., Meijers, Caro M., Mei, Hailiang, Michailidou, Kyriaki, Dennis, Joe, Hogervorst, Frans B. L., Nederlof, Petra M., van Asperen, Christi J., Devilee, Peter
Publicado no Int J Cancer (2020)

Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers

Por Holstege, Henne, van Beers, Erik, Velds, Arno, Liu, Xiaoling, Joosse, Simon A, Klarenbeek, Sjoerd, Schut, Eva, Kerkhoven, Ron, Klijn, Christiaan N, Wessels, Lodewyk FA, Nederlof, Petra M, Jonkers, Jos
Publicado em 2010

Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling

Por Hilbers, Florentine S., Meijers, Caro M., Laros, Jeroen F. J., van Galen, Michiel, Hoogerbrugge, Nicoline, Vasen, Hans F. A., Nederlof, Petra M., Wijnen, Juul T., van Asperen, Christi J., Devilee, Peter
Publicado em 2013

Rapid KRAS, EGFR, BRAF and PIK3CA Mutation Analysis of Fine Needle Aspirates from Non-Small-Cell Lung Cancer Using Allele-Specific qPCR

Por van Eijk, Ronald, Licht, Jappe, Schrumpf, Melanie, Talebian Yazdi, Mehrdad, Ruano, Dina, Forte, Giusi I., Nederlof, Petra M., Veselic, Maud, Rabe, Klaus F., Annema, Jouke T., Smit, Vincent, Morreau, Hans, van Wezel, Tom
Publicado em 2011

Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response

Por Lips, Esther H., Michaut, Magali, Hoogstraat, Marlous, Mulder, Lennart, Besselink, Nicolle JM, Koudijs, Marco J., Cuppen, Edwin, Voest, Emile E., Bernards, Rene, Nederlof, Petra M., Wesseling, Jelle, Rodenhuis, Sjoerd, Wessels, Lodewyk FA
Publicado no Breast Cancer Res (2015)

Identification of BRCA1-like triple-negative breast cancers by quantitative multiplex-ligation-dependent probe amplification (MLPA) analysis of BRCA1-associated chromosomal regions...

Por Gross, Eva, van Tinteren, Harm, Li, Zhou, Raab, Sandra, Meul, Christina, Avril, Stefanie, Laddach, Nadja, Aubele, Michaela, Propping, Corinna, Gkazepis, Apostolos, Schmitt, Manfred, Meindl, Alfons, Nederlof, Petra M., Kiechle, Marion, Lips, Esther H.
Publicado no BMC Cancer (2016)